Economic Evaluation of Budesonide Orodispersible Tablets for the Treatment of Eosinophilic Esophagitis: A Cost-Utility Analysis.

Catherine BeaucheminA CastonguayE S ChanE S DellonB G FeaganC MaS WasermanJ CookD Claveau

Published in: Advances in therapy (2021)

BOT was cost-effective compared to no treatment for both the induction and maintenance of clinico-pathological remission of EoE in patients non-responsive to PPIs.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
rheumatoid arthritis
peritoneal dialysis
drug delivery
patient reported outcomes
ulcerative colitis